Antisense p53 decreases production of VEGF in follicular thyroid cancer cells

Endocrine

Volumn 29, Issue 3, 2006, Pages 409-412

  Hassan, I ^a   Wunderlich, A ^a   Slater, E ^a   Hoffmann, S ^a   Celik, I ^a   Zielke, A ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Angiogenesis; FTC 133 cell line; ODN; p53; Undifferentiated thyroid cancer; VEGF

Indexed keywords

OLIGODEOXYRIBONUCLEOTIDE; PROTEIN P53; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME IMMUNOASSAY; EXON; GENE MUTATION; GENETIC TRANSFECTION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECESSIVE GENE; THYROID CANCER; THYROID FOLLICLE CELL;

EID: 33748480113     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:29:3:409     Document Type: Article

References (19)

1. Nagayama, Y., Shigematsu, K., Namba, H., Zeki, K., Yamashita, S., and Niwa, M. (2000). Anticancer Res. 20(4), 2723-2728.
2. Mukhopadhyay, D., Tsoiakas, L., and Sukhatme, V. P. (1995). Cancer Res. 55(24), 6161-6165.
3. Narimatsu, M., Nagayama, Y., Akino, K., et al. (1998). J. Clin. Endocrinol. Metab. 83(10), 3668-3672.
4. Stein, C. A. and Cheng, Y. C. (1993). Science 261, 1004-1012.
5. Fiedler, A., Knorre, Ch., Franke, Y., et al. (1998). Langenbeck's Arch. Surg. 383, 269-275.
6. Bayever, E., Haines, K. M., Iversen, P. L., et al. (1993). Leuk. Lymphoma 12, 223-231.
7. Jossart, G. H., Epstein, H. D., Shaver, J. K., et al. (1996). J. Clin. Endocrinol. Metab. 81(10), 3498-3504.
8. Soh, E. Y., Duh, Q. Y., Sobhi, S. A., et al. (1997). J. Clin. Endocrinol. Metab. 82(11), 3741-3747.
9. Wynford-Thomas, D. (1999). Horm. Res. 47, 145-157.
10. La Perle, K. M., Jhiang, S. M., and Capen, C. C. (2000). Am. J. Pathol. 157, 671-677.
11. McIver, B., Hay, I. D., Giuffrida, D. F., et al. (2001). Surgery 130, 1028-1034.
12. Lessin, L. S. and Min, M. (2000). In: Thyroid cancer: a comprehensive guide to clinical management. Wartofsky, L. (ed.). Humana Press: Totowa, NJ, pp. 337-340.
13. Folkmann, J. (1986). Cancer Res. 46, 467-473.
14. Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. (1994). Science 265, 1582-1584.
15. Bauer, A. J., Terrell, R., Doniparthi, N. K., et al. (2002). Thyroid 12, 953-961.
16. Bauer, A. J., Patel, A., Terrell, R., et al. (2003). Ann. Clin. Lab. Sci. 33(2), 192-199.
17. Yu, J. I., Rak, J. W., Coomber, B. L., Hicklin, D. J., and Kerbel, R. S. (2002). Science 295(5559), 1526-1528.
18. Hoffmann, S., Hofbauer, L. C., Scharrenbach, V., et al. (2004). J. Clin. Endocrinol. Metab. 89, 6139-6145.
19. Zielke, A., Wong, M. G., Siperstein, A. E., Clark, O. H., Rothmund, M., and Duh, Q. Y. (1997). J. Surg. Oncol. 66, 11-18.